Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33742 | 86 | 54.0 | 87% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MEMBRANE LIPID THERAPY | Author keyword | 18 | 89% | 9% | 8 |
2 | MOL CELL BIOMED | Address | 12 | 59% | 15% | 13 |
3 | MOL CELLULAR BIOMED | Address | 9 | 64% | 10% | 9 |
4 | 2 HYDROXYOLEIC ACID | Author keyword | 1 | 50% | 2% | 2 |
5 | CSIC GRASAASSOCIATE UNIT | Address | 1 | 100% | 2% | 2 |
6 | LIPID MEMBRANE STRUCTURE | Author keyword | 1 | 50% | 2% | 2 |
7 | LIPOPHARMA THER EUT SL | Address | 1 | 100% | 2% | 2 |
8 | NANOMED SCI | Address | 1 | 21% | 5% | 4 |
9 | 2 HYDROXYLATED FATTY ACID | Author keyword | 1 | 50% | 1% | 1 |
10 | FUNCTION AND PATHWAY ANNOTATION | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 2 HYDROXYOLEIC ACID | 12 | 63% | 14% | 12 |
2 | HYPERFLUIDIZATION | 6 | 80% | 5% | 4 |
3 | MINERVAL | 6 | 100% | 5% | 4 |
4 | NONLAMELLAR MEMBRANE STRUCTURES | 1 | 100% | 2% | 2 |
5 | PROTEIN RESPONSE | 1 | 11% | 7% | 6 |
6 | PHOSPHATIDYLETHANOLAMINE MODEL MEMBRANES | 1 | 25% | 2% | 2 |
7 | PROTEASE ACTIVATED RECEPTOR | 0 | 20% | 2% | 2 |
8 | BETA P 1 40 | 0 | 33% | 1% | 1 |
9 | DIETARY OLEIC ACID | 0 | 33% | 1% | 1 |
10 | GLYCOLIPOSOMES | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Membrane-lipid therapy: a new approach in molecular medicine | 2006 | 80 | 69 | 22% |
Regulation of the cancer cell membrane lipid composition by NaCHOleate Effects on cell signaling and therapeutical relevance in glioma | 2014 | 1 | 72 | 31% |
Membrane fluidity matters: Hyperthermia from the aspects of lipids and membranes | 2013 | 8 | 81 | 17% |
The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health | 2014 | 2 | 126 | 19% |
Key role of lipids in heat stress management | 2013 | 5 | 134 | 10% |
Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment | 2015 | 0 | 180 | 19% |
Membranes: a meeting point for lipids, proteins and therapies | 2008 | 66 | 314 | 5% |
The significance of lipid composition for membrane activity: New concepts and ways of assessing function | 2005 | 98 | 357 | 4% |
Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review | 2014 | 4 | 46 | 2% |
Prioritizing the proteome: identifying pharmaceutically relevant targets | 2002 | 12 | 29 | 3% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CELL BIOMED | 12 | 59% | 15% | 13 |
2 | MOL CELLULAR BIOMED | 9 | 64% | 10% | 9 |
3 | CSIC GRASAASSOCIATE UNIT | 1 | 100% | 2.3% | 2 |
4 | LIPOPHARMA THER EUT SL | 1 | 100% | 2.3% | 2 |
5 | NANOMED SCI | 1 | 21% | 4.7% | 4 |
6 | INVEST BIOMED RED ENFERMEDADES NEURDEGENERAT | 0 | 33% | 1.2% | 1 |
7 | INVEST CIENCIES SALUT | 0 | 33% | 1.2% | 1 |
8 | MOL ST S BIOL | 0 | 25% | 1.2% | 1 |
9 | OUTPATIENT MED | 0 | 20% | 1.2% | 1 |
10 | UNIDAD MIXTA INVEST PRINCIPE FELIPE | 0 | 20% | 1.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195715 | GI ALPHA PROTEINS//GI ALPHA PROTEIN//GQALPHA PROTEIN |
2 | 0.0000157087 | PHOSPHATIDYLGLUCOSIDE//CHOLESTEROL ALPHA GLUCOSYLTRANSFERASE//EURYALE FEROX |
3 | 0.0000124824 | PHARMACOL CARDIOVASC EXPT BIOMOL//CRIT CARE MED OSB5//HEAT STRESS PROTEIN |
4 | 0.0000104146 | GPRC5A//GNAS1//CELLULAR SIGNALINGCANC |
5 | 0.0000098292 | LIQUID ORDERED PHASE//LIQUID ORDERED//CHOLESTATRIENOL |
6 | 0.0000097285 | HSF1//HEAT SHOCK FACTOR//HEAT SHOCK FACTOR 1 |
7 | 0.0000081079 | INTERDIGITATED GEL PHASE//SUBGEL PHASE//A LAIDLAWII |
8 | 0.0000077911 | HOMEOVISCOUS ADAPTATION//SERINE EXCHANGE//1 4 TRIMETHYLAMMONIUMPHENYL 6 PHENYL 1 3 5 HEXATRIENE |
9 | 0.0000066164 | HEMOPEXIN//WAP65//RABBIT HEMOPEXIN |
10 | 0.0000064752 | HCCR 1//HUMAN CERVICAL CANCER ONCOGENE//HCCR |